Get started
Author

Andrea Rizzuto

Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials
2023 · Andrea Rizzuto, Angelo Pirrera, et al. · International Journal of Molecular Sciences · 11
PDF
CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues
2025 · Caterina Alati, Martina Pitea, et al. · Cancers · 8
PDF
SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma
2025 · Caterina Alati, Martina Pitea, et al. · Cancers · 5
PDF
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant-eligible newly diagnosed multiple myeloma: a multicenter real-world experience
2024 · Marika Porrazzo, Tiziana Moscato, et al. · Haematologica · 2
PDF
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients
2024 · Emilia Gigliotta, Federica Plano, et al. · Experimental Hematology and Oncology · 1
PDF
Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience
2026 · Cirino Botta, Andrea Rizzuto, et al. · Haematologica
Inflammatory Biomarkers for Thrombotic Risk Assessment in Multiple Myeloma Patients on IMiD/aCD38-Based Regimens: Insights from a Prospective Observational Study
2025 · Cirino Botta, Anna Maria Corsale, et al. · Biomolecules
PDF
Integrated Multi-Omic Profiling of Immune, Soluble, and Microbial Signatures Identifies Predictors of Multiple Myeloma Evolution
2025 · Anna Maria Corsale, Marta Di Simone, et al. · Clinical Lymphoma Myeloma & Leukemia
P-204 Deciphering the Interplay of Immune Alterations and Microbiome Changes Along Multiple Myeloma Evolution From Premalignant Conditions
2024 · Anna Maria Corsale, Mojtaba Shekarkar Azgomi, et al. · Clinical Lymphoma Myeloma & Leukemia
P-059 Integrative radiomic and immunological analysis for risk classification and outcome prediction in monoclonal gammopathies
2023 · Emilia Gigliotta, Andrea Rizzuto, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 14
Citation count: 27
H-index: 3
I10-index: 1
Year
Topic
Type